ENTITY

Concord Biotech Ltd (CONCORDB IN)

24
Analysis
Health CareIndia
Concord Biotech Ltd. provides pharmaceutical products. The Company offers active pharmaceutical ingredients, finished dosages formulations, and other related products, as well as provides contract research and manufacturing services. Concord Biotech serves customers in India.
more
bullishNissan Motor
12 Feb 2024 08:08

ECM Weekly (12th Feb 2024) - Nissan/Renault, Metcash, Digital Core, SBFC, Thai Credit, Park Hotel

Aequitas Research puts out a weekly update on the deals that were covered by the team recently along with updates for upcoming IPOs.

Logo
577 Views
Share
bullishLawson Inc
11 Feb 2024 07:00

Last Week in Event SPACE: Mitsui Fudosan/Oriental Land, Giordano, JSR, Pasona, Lawson, L'Occitane

The weekend is here! Pour yourself a coffee, grab a comfortable seat, and sift through a brief summary of insights on various events discussed...

Logo
634 Views
Share
09 Feb 2024 05:15

Entero Healthcare IPO - Profitability Not Out of the Woods Yet

Entero Healthcare Solutions Limited (2294842D IN) is looking to raise US$193m in its India IPO. In this note, we will look at the RHP updates, and...

Logo
474 Views
Share
20 Dec 2023 06:11

AMFI Stock Reclassification Preview (Dec 2023): MidCap to LargeCap Migrations Outperforming

We see 41 stocks migrating between different market cap segments in Jan. A lot of stocks will have passive flows from NIFTY, NIFTYJR and global...

Logo
491 Views
Share
01 Dec 2023 19:25

Concord Biotech Ltd (658823Z IN): Q2 EBITDA and PAT Triples on Operational Efficiencies

In Q2FY24, Concord’s EBITDA and PAT grew to INR1,160M and INR810M from INR370M and INR220M, respectively in Q2FY23. With new capacities coming on...

Logo
527 Views
Share
x